These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16917801

  • 1. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
    Serratì S, Cinelli M, Margheri F, Guiducci S, Del Rosso A, Pucci M, Fibbi G, Bazzichi L, Bombardieri S, Matucci-Cerinic M, Del Rosso M.
    J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
    D'Alessio S, Fibbi G, Cinelli M, Guiducci S, Del Rosso A, Margheri F, Serratì S, Pucci M, Kahaleh B, Fan P, Annunziato F, Cosmi L, Liotta F, Matucci-Cerinic M, Del Rosso M.
    Arthritis Rheum; 2004 Oct; 50(10):3275-85. PubMed ID: 15476218
    [Abstract] [Full Text] [Related]

  • 3. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F, D'Alessio S, Serratì S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan DM, Albini A, Fibbi G, Del Rosso M.
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [Abstract] [Full Text] [Related]

  • 4. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.
    Margheri F, Serratì S, Lapucci A, Chillà A, Bazzichi L, Bombardieri S, Kahaleh B, Calorini L, Bianchini F, Fibbi G, Del Rosso M.
    Arthritis Rheum; 2010 Aug; 62(8):2488-98. PubMed ID: 20506099
    [Abstract] [Full Text] [Related]

  • 5. The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.
    Giusti B, Serratì S, Margheri F, Papucci L, Rossi L, Poggi F, Magi A, Del Rosso A, Cinelli M, Guiducci S, Kahaleh B, Matucci-Cerinic M, Abbate R, Fibbi G, Del Rosso M.
    Arthritis Rheum; 2005 Nov; 52(11):3618-28. PubMed ID: 16255054
    [Abstract] [Full Text] [Related]

  • 6. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.
    Serratì S, Margheri F, Fibbi G, Di Cara G, Minafra L, Pucci-Minafra I, Liotta F, Annunziato F, Pucci M, Del Rosso M.
    J Pathol; 2008 Apr; 214(5):545-54. PubMed ID: 18189329
    [Abstract] [Full Text] [Related]

  • 7. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors.
    Basire A, Sabatier F, Ravet S, Lamy E, Mialhe A, Zabouo G, Paul P, Gurewich V, Sampol J, Dignat-George F.
    Thromb Haemost; 2006 Apr; 95(4):678-88. PubMed ID: 16601839
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 9. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G, Caldini R, Chevanne M, Pucci M, Schiavone N, Morbidelli L, Parenti A, Granger HJ, Del Rosso M, Ziche M.
    Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
    [Abstract] [Full Text] [Related]

  • 10. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S, Cozzi F, Burger D, Dayer JM, Meroni PL, Chizzolini C.
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [Abstract] [Full Text] [Related]

  • 11. Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells.
    Margheri F, Manetti M, Serratì S, Nosi D, Pucci M, Matucci-Cerinic M, Kahaleh B, Bazzichi L, Fibbi G, Ibba-Manneschi L, Del Rosso M.
    Arthritis Rheum; 2006 Dec; 54(12):3926-38. PubMed ID: 17133606
    [Abstract] [Full Text] [Related]

  • 12. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N, Pfeffer U, Dell'Eva R, Ambrosini C, Noonan DM, Albini A.
    Clin Cancer Res; 2005 Jun 15; 11(12):4610-9. PubMed ID: 15958647
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, Milia AF, Bellando-Randone S, Fiori G, Conforti ML, Saccardi R, Ibba-Manneschi L, Matucci-Cerinic M.
    Ann Rheum Dis; 2011 Nov 15; 70(11):2011-21. PubMed ID: 21821866
    [Abstract] [Full Text] [Related]

  • 14. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
    Serratì S, Chillà A, Laurenzana A, Margheri F, Giannoni E, Magnelli L, Chiarugi P, Dotor J, Feijoo E, Bazzichi L, Bombardieri S, Kahaleh B, Fibbi G, Del Rosso M.
    Arthritis Rheum; 2013 Jan 15; 65(1):258-69. PubMed ID: 22972461
    [Abstract] [Full Text] [Related]

  • 15. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, Dolo V, Pavan A, Saccardi R, Tyndall A, Giacomelli R, Cerinic MM.
    Arthritis Rheum; 2007 Jun 15; 56(6):1994-2004. PubMed ID: 17530639
    [Abstract] [Full Text] [Related]

  • 16. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
    Avouac J, Wipff J, Goldman O, Ruiz B, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y.
    Arthritis Rheum; 2008 Nov 15; 58(11):3550-61. PubMed ID: 18975312
    [Abstract] [Full Text] [Related]

  • 17. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y, Nagakawa O, Murakami K, Fuse H, Saiki I.
    Oncol Rep; 2003 Nov 15; 10(4):1001-6. PubMed ID: 12792760
    [Abstract] [Full Text] [Related]

  • 18. Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells.
    Seghezzi G, Marelli R, Mandriota SJ, Nolli ML, Mazzieri R, Mignatti P.
    J Cell Physiol; 1996 Nov 15; 169(2):300-8. PubMed ID: 8908197
    [Abstract] [Full Text] [Related]

  • 19. Novel function of ascorbic acid as an angiostatic factor.
    Ashino H, Shimamura M, Nakajima H, Dombou M, Kawanaka S, Oikawa T, Iwaguchi T, Kawashima S.
    Angiogenesis; 2003 Nov 15; 6(4):259-69. PubMed ID: 15166494
    [Abstract] [Full Text] [Related]

  • 20. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C, Parel Y, De Luca C, Tyndall A, Akesson A, Scheja A, Dayer JM.
    Arthritis Rheum; 2003 Sep 15; 48(9):2593-604. PubMed ID: 13130479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.